An interventional study of Online Cognitive Behavioural Therapy in Depression / Major Depressive Disorder and Bipolar Disorder (BD), sponsored by Centre for Addiction and Mental Health. Enrolling by invitation at 1 site in Canada. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-08-27.
Sponsored by Centre for Addiction and Mental Health · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 48 studies in Depression by Centre for Addiction and Mental Health — 6 open to participants now, 8 under way, none of them phase 3. Depression · Centre for Addiction and Mental Health.
Among the 48 studies in Depression by Centre for Addiction and Mental Health, this one is the 10th largest by planned enrollment of the 46 interventional ones that give a count, is one of 2 that started in 2026, is one of 39 with no phase, and was the 48th registered.
8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.
Browse Depression studies →6 of the 48 studies in Depression by Centre for Addiction and Mental Health are open now, in 1 country. Recruiting first, the newest first:
Centre for Addiction and Mental Health · Sites in Canada
Ages 18–65
Centre for Addiction and Mental Health · Sites in Canada
Ages 18–50
Centre for Addiction and Mental Health · Sites in Canada
Ages 50+
Centre for Addiction and Mental Health · Sites in Canada
Ages 13–18 · Healthy volunteers
Centre for Addiction and Mental Health · Sites in Canada
Ages 18–55
By country, each count listing its studies:
Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.
This study: 16 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
48 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 3 · Phase 4 2
First in 2001; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is above the median of 81 across 7,089 interventional studies indexed under Depression.
Median enrollment 74 across the 46 interventional studies, 283 across the 2 observational. Of the 38 that completed or were terminated, 1 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
Centre for Addiction and Mental Health is the lead sponsor of 339 studies on the registry; 51 are open to participants now.
2 of the studies in Depression by Centre for Addiction and Mental Health that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04935619Centre for Addiction and Mental HealthExtended Effects of Cannabis Abstinence on Clinical Symptoms and Cognition in Depression | 2027-06-30 |
| NCT05142683Centre for Addiction and Mental HealthEffectiveness of an Integrated Care Pathway for Depression: Cluster Randomized Controlled Trial | 2027-09-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 48 studies in Depression by Centre for Addiction and Mental Health, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The proposed study will be a single-arm pragmatic clinical trial examining the feasibility of online CBT within the CAN-BIND sites and the biomarkers of treatment response to online CBT for mood disorders.
A total of 200 participants from the Canadian Biomarker Integration Network in Depression (CAN-BIND) network research sites will receive access to the Wellbeing Course for 8 Weeks with a 6-month follow-up period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
1. Exclusion criteria for the current study include not meeting inclusion criteria only
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The Wellbeing Course is an online intervention offered through the Online Therapy Unit to support people dealing with mood disorders. The course consists of 5 core lessons that provides psychoeducation on effective cognitive behavioural techniques for managing symptoms of depression and/or anxiety with short video overviews, client stories and interactive exercises. Participants will engage with the course for 8-weeks during the intervention period but will receive access for 1-year. Participants will also complete study assessments after the intervention period and then bimonthly assessments during the follow-up phase.
Behavioral: Online Cognitive Behavioural Therapy
The Wellbeing course is an online program that educates and guides users in cognitive behavioural therapy techniques with downloadable guides, client stories and interactive exercises to help manage symptoms of mood concerns.
Also known as: Wellbeing Course
Quick Inventory of Depressive Symptomatology - Self Report (QIDS-SR)
A widely used and well-validated, 16-item measure of depression symptoms. Minimum score is 0 and Maximum score is 27, with higher scores indicating severe depression.
Time frame: Baseline, Week 8, Week 16, Week 24, Week 32
Patient Health Questionnaire - 9 (PHQ-9)
A widely used and well-validated, 9-item measure of depression symptoms. Minimum score is 0 and Maximum score is 27, with higher scores indicating severe depression.
Time frame: Baseline, Week 8, Week 16, Week 24, Week 32
Generalized Anxiety Disorder - 7 (GAD-7)
A widely used and well-validated, 7-item measure of symptoms of anxiety. Minimum score is 0 and Maximum score is 21, with higher scores indicating severe anxiety.
Time frame: Baseline, Week 8, Week 16, Week 24, Week 32
Snaith-Hamilton Pleasure Scale (SHAPS)
A widely used and well-validated 14-item measure of the ability to experience pleasure. Minimum score is 0 and Maximum score is 14, with higher scores indicating greater pleasure.
Time frame: Baseline, Week 8, Week 16, Week 24, Week 32
Work and Social Adjustment Scale (WSAS)
A 5-item measure of the impact of mental health conditions on daily functioning. Minimum score is 0 and Maximum score is 40, with higher scores indicating greater impairment in overall functioning.
Time frame: Baseline, Week 8, Week 16, Week 24, Week 32
The World Health Organization-Five Well-Being Index (WHO-5)
A 5-item short form of quality of life across multiple domains. Raw scores range from 0 to 25 and can be converted to a percentage score ranging from 0 to 100, with higher scores indicating better mental well-being.
Time frame: Baseline, Week 8, Week 16, Week 24, Week 32
Perseverative Thinking Questionnaire (PTQ)
A 15-item measure that assesses the underlying process of repetitive negative thinking, independent of specific thought content or diagnostic category. Minimum score is 0 and Maximum score is 60, with higher score indicating more frequent and intrusive negative thought patterns.
Time frame: Baseline, Week 8, Week 16, Week 24, Week 32
Ruminative Response Scale (RRS) - Brooding Subscale
A 5-item measure of maladaptive rumination. Minimum score is 5 and Maximum score is 20, with higher scores indicating greater brooding.
Time frame: Baseline, Week 8, Week 16, Week 24, Week 32
Childhood Experience of Care and Abuse Questionnaire (CECA.Q)
A self-report measure assessing negative childhood experiences before age 17, including Neglect and Abuse. Sub-scale scores are derived by summing relevant items, with established cut-offs for severity of Neglect, Antipathy, Physical and Sexual abuse. Minimum score for Antipathy or Neglect is 8 and Maximum score is 40. A cutoff of \>=25 for severity of Antipathy mother/father while cutoff for severity of Neglect is \>=22 for mother and \>=24 for father. Minimum score for severity of Physical abuse is 0 and Maximum score is 4. Minimum score for severity of Sexual abuse is 0 and Maximum score is 7. The cutoff for severity of Physical and Sexual abuse is \>=1. Higher scores across all subscales (Antipathy, Neglect, Physical abuse, Sexual abuse) indicates greater severity. Loss and Support are also reported in this measure and scored as present or absent. Loss reflects parental death before age 17 or separation of 1+ year while Support reflects presence of at least one support figure.
Time frame: Baseline
Plan to share: Yes — This study is funded by Ontario Brain Institue (OBI). Data collected during the duration of the study will be entered into a database known as "Brain-CODE", which is an open-access database with high level security protocols that allows for the sharing of coded data with other researchers in Canada or around the world.
Supporting information: Study protocol
Time frame: Within 12 months of study completion
Access criteria: Access to IPD and supporting information is through submission of a detailed research analysis proposal that will be reviewed by Ontario Brain Institute (OBI) and the executive committees of Canadian Biomarker Integration Network in Depression (CAN-BIND). For researchers outside Canada or not affiliated with CAN-BIND, they will need to establish a Data Use Agreement with OBI before they can access any data from CAN-BIND.
Data sharing details ↗ · braininstitute.ca
Started Jul 2026 (actual). Primary completion is estimated for Jul 2029, 36 months after the start.
Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 36 months is above that.
Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre for Addiction and Mental Health →